<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34618203</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>142</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>Nuclear depletion of RNA-binding protein ELAVL3 (HuC) in sporadic and familial amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>985</StartPage><EndPage>1001</EndPage><MedlinePgn>985-1001</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-021-02374-4</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a progressive fatal neurodegenerative disease caused by loss of motor neurons and characterized neuropathologically in almost all cases by nuclear depletion and cytoplasmic aggregation of TDP-43, a nuclear RNA-binding protein (RBP). We identified ELAVL3 as one of the most downregulated genes in our transcriptome profiles of laser captured microdissection of motor neurons from sporadic ALS nervous systems and the most dysregulated of all RBPs. Neuropathological characterizations showed ELAVL3 nuclear depletion in a great percentage of remnant motor neurons, sometimes accompanied by cytoplasmic accumulations. These abnormalities were common in sporadic cases with and without intermediate expansions in ATXN2 and familial cases carrying mutations in C9orf72 and SOD1. Depletion of ELAVL3 occurred at both the RNA and protein levels and a short protein isoform was identified, but it is not related to a TDP-43-dependent cryptic exon in intron 3. Strikingly, ELAVL3 abnormalities were more frequent than TDP-43 abnormalities and occurred in motor neurons still with normal nuclear TDP-43 present, but all neurons with abnormal TDP-43 also had abnormal ELAVL3. In a neuron-like cell culture model using SH-SY5Y cells, ELAVL3 mislocalization occurred weeks before TDP-43 abnormalities were seen. We interrogated genetic databases, but did not identify association of ELAVL3 genetic structure with ALS. Taken together, these findings suggest that ELAVL3 is an important RBP in ALS pathogenesis acquired early and the neuropathological data suggest that it is involved by loss of function rather than cytoplasmic toxicity.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Diaz-Garcia</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093-0670, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Vivian I</ForeName><Initials>VI</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093-0670, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vazquez-Sanchez</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, 92093-0670, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892-3707, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arogundade</LastName><ForeName>Olubankole Aladesuyi</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093-0670, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Maria J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093-0670, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traynor</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, 20892-3707, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cleveland</LastName><ForeName>Don</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, 92093-0670, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Ludwig Institute for Cancer Research, University of California at San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravits</LastName><ForeName>John</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6521-4649</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, University of California, San Diego, La Jolla, CA, 92093-0670, USA. jravits@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 NS047101</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS088578</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS121805</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21NS121805</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067778">ELAV-Like Protein 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C490264">ELAVL3 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002467" MajorTopicYN="N">Cell Nucleus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067778" MajorTopicYN="N">ELAV-Like Protein 3</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">ATXN2</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">ELAVL3</Keyword><Keyword MajorTopicYN="N">Loss of function</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Nuclear depletion</Keyword><Keyword MajorTopicYN="N">RNA-binding proteins</Keyword><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>7</Day><Hour>12</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34618203</ArticleId><ArticleId IdType="pmc">PMC8568872</ArticleId><ArticleId IdType="doi">10.1007/s00401-021-02374-4</ArticleId><ArticleId IdType="pii">10.1007/s00401-021-02374-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aladesuyi Arogundade O, Nguyen S, Leung R, Wainio D, Rodriguez M, Ravits J. Nucleolar stress in C9orf72 and sporadic ALS spinal motor neurons precedes TDP-43 mislocalization. Acta Neuropathol Commun. 2021;9:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885352</ArticleId><ArticleId IdType="pubmed">33588953</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Skelt L, Notaro A, Highley JR, Fox AH, La Bella V, et al. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol Commun. 2019;7:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakheet T, Hitti E, Al-Saif M, Moghrabi WN, Khabar KSA. The AU-rich element landscape across human transcriptome reveals a large proportion in introns and regulation by ELAVL1/HuR. Biochim Biophys Acta Gene Regul Mech. 2018;1861:167&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pubmed">29413897</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, Finkbeiner S. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis. J Neurosci. 2010;30:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2821110</ArticleId><ArticleId IdType="pubmed">20071528</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Weishaupt JH. Update on amyotrophic lateral sclerosis genetics. Curr Opin Neurol. 2019;32:735&#x2013;739.</Citation><ArticleIdList><ArticleId IdType="pubmed">31335339</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AA-L, Wilkins OG, Keuss MJ, Hill SE, Zanovello M, Lee WC et al (2021) Common ALS/FTD risk variants in UNC13A exacerbate its cryptic splicing 2 and loss upon TDP-43 mislocalization. bioRxiv. 10.1101/2021.04.02.438170</Citation></Reference><Reference><Citation>Colombrita C, Onesto E, Buratti E, de la Grange P, Gumina V, Baralle FE, et al. From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models. Biochim Biophys Acta. 2015;1849:1398&#x2013;1410.</Citation><ArticleIdList><ArticleId IdType="pubmed">26514432</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R, et al. A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci USA. 2011;108:20881&#x2013;20890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragnaz L, Klima R, Skoko N, Budini M, Feiguin F, Baralle FE. Aggregate formation prevents dTDP-43 neurotoxicity in the Drosophila melanogaster eye. Neurobiol Dis. 2014;71:74&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">25088712</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J, Furneaux HM, Gralla RJ, Kris MG, Posner JB. Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer&#x2014;a quantitative western blot analysis. Ann Neurol. 1990;27:544&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">2163235</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C, Zhang H, Su Y, Silani V, Singer RH, Rossoll W, et al. The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons. J Neurosci. 2011;31:3914&#x2013;3925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3070748</ArticleId><ArticleId IdType="pubmed">21389246</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallmann J, Sedlyarov V, Tanzer A, Kovarik P, Hofacker IL. AREsite2: an enhanced database for the comprehensive investigation of AU/GU/U-rich elements. Nucleic Acids Res. 2016;44:D90&#x2013;D95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4702876</ArticleId><ArticleId IdType="pubmed">26602692</ArticleId></ArticleIdList></Reference><Reference><Citation>Fifita JA, Zhang KY, Galper J, Williams KL, McCann EP, Hogan AL, et al. Genetic and pathological assessment of hnRNPA1, hnRNPA2/B1, and hnRNPA3 in familial and sporadic amyotrophic lateral sclerosis. Neurodegener Dis. 2017;17:304&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">29131108</ArticleId></ArticleIdList></Reference><Reference><Citation>Fragkouli A, Koukouraki P, Vlachos IS, Paraskevopoulou MD, Hatzigeorgiou AG, Doxakis E. Neuronal ELAVL proteins utilize AUF-1 as a co-partner to induce neuron-specific alternative splicing of APP. Sci Rep. 2017;7:44507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5349543</ArticleId><ArticleId IdType="pubmed">28291226</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F, Lu S, Yu H, Chen C, Melamed Z, Guo L, et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 2019;102:339&#x2013;357.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin KM, Chang L, Monteiro MJ. ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum Mol Genet. 2015;24:2565&#x2013;2577.</Citation><ArticleIdList><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X, Luo F, Li Y, Zhou H, Qin Z, Liu Z, et al. Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly. Nat Commun. 2019;10:2006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6494871</ArticleId><ArticleId IdType="pubmed">31043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer RC, Chami AA, de Assis DR, Vourc&#x2019;h P, Andres CR, Corcia P, et al. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? Brain. 2019;142:1176&#x2013;1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilgers V. Alternative polyadenylation coupled to transcription initiation: Insights from ELAV-mediated 3&#x2032; UTR extension. RNA Biol. 2015;12:918&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615838</ArticleId><ArticleId IdType="pubmed">26158379</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinman MN, Lou H. Diverse molecular functions of Hu proteins. Cell Mol Life Sci. 2008;65:3168&#x2013;3181.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2580827</ArticleId><ArticleId IdType="pubmed">18581050</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R, Workman MJ, Mathkar P, Wu K, Kim KJ, O&#x2019;Rourke JG, et al. Cross-comparison of human iPSC motor neuron models of familial and sporadic ALS reveals early and convergent transcriptomic disease signatures. Cell Syst. 2021;12:159&#x2013;175.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7897311</ArticleId><ArticleId IdType="pubmed">33382996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince-Dunn G, Okano HJ, Jensen KB, Park W-Y, Zhong R, Ule J, et al. Neuronal Elav-like (Hu) proteins regulate RNA splicing and abundance to control glutamate levels and neuronal excitability. Neuron. 2012;75:1067&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3517991</ArticleId><ArticleId IdType="pubmed">22998874</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat Neurosci. 2014;17:664&#x2013;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakumoto K, Miyazaki T, Watanabe M, Darnell RB, Okano H, Okano H. The maintenance of Purkinje axons by HuC in adult cerebellum. Neurosci Res. 2010;68:e61.</Citation></Reference><Reference><Citation>Kakumoto K, Miyazaki T, Watanabe M, Darnell R, Okano H, Okano H. The maintenance of Purkinje axons by an RNA-binding protein HuC in adult cerebellum. Neurosci Res. 2011;71:e95&#x2013;e96.</Citation></Reference><Reference><Citation>Kapeli K, Martinez FJ, Yeo GW. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum Genet. 2017;136:1193&#x2013;1214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K, Pratt GA, Vu AQ, Hutt KR, Martinez FJ, Sundararaman B, et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat Commun. 2016;7:12143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942&#x2013;955.</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Kim NC, Wang Y-D, Scarborough EA, Moore J, Diaz Z, et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>King PH, Redden D, Palmgren JS, Nabors LB, Lennon VA. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease. J Autoimmun. 1999;13:435&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pubmed">10585760</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, Williams LA, Limone F, Guerra San Juan I, Davis-Dusenbery BN, Mordes DA, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat Neurosci. 2019;22:167&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Krach F, Batra R, Wheeler EC, Vu AQ, Wang R, Hutt K, et al. Transcriptome-pathology correlation identifies interplay between TDP-43 and the expression of its kinase CK1E in sporadic ALS. Acta Neuropathol. 2018;136:405&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6215775</ArticleId><ArticleId IdType="pubmed">29881994</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski TJ, Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, et al. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009;323:1205&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y-L, Liu Y, Yoo AS (2020) Synergism between microRNA-124 and ELAVL3 drives neuronal gene upregulation during direct neuronal reprogramming of human fibroblasts. bioRxiv. 2020.03.25.006635</Citation></Reference><Reference><Citation>Luo N-A, Qu Y-Q, Yang G-D, Wang T, Li R-L, Jia L-T, et al. Post-transcriptional up-regulation of PDGF-C by HuR in advanced and stressed breast cancer. Int J Mol Sci. 2014;15:20306&#x2013;20320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4264168</ArticleId><ArticleId IdType="pubmed">25383675</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma WJ, Chung S, Furneaux H. The Elav-like proteins bind to AU-rich elements and to the poly(A) tail of mRNA. Nucleic Acids Res. 1997;25:3564&#x2013;3569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC146929</ArticleId><ArticleId IdType="pubmed">9278474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007;61:427&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">17469116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22:180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;l&#xe9; N, Berzero G, Maisonobe T, Salachas F, Nicolas G, Weiss N, et al. Motor neuron disease of paraneoplastic origin: a rare but treatable condition. J Neurol. 2018;265:1590&#x2013;1599.</Citation><ArticleIdList><ArticleId IdType="pubmed">29725842</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani P, Amadio M, Laforenza U, Dell&#x2019;Orco M, Diamanti L, Sardone V, et al. Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS. Neurobiol Dis. 2013;60:51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">23969235</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Bentmann E, Dormann D, Jawaid A, DeJesus-Hernandez M, Ansorge O, et al. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134:2595&#x2013;2609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al. Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron. 2018;97:1268&#x2013;1283.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan M, Talbot K, Ansorge O. Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathol Commun. 2016;4:99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5011941</ArticleId><ArticleId IdType="pubmed">27600654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa Y, Kakumoto K, Yoshida T, Kuwako K-I, Miyazaki T, Yamaguchi J, et al. Elavl3 is essential for the maintenance of Purkinje neuron axons. Sci Rep. 2018;8:2722.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5807307</ArticleId><ArticleId IdType="pubmed">29426875</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa Y, Yamaguchi J, Yano M, Uchiyama Y, Okano HJ. Elavl3 regulates neuronal polarity through the alternative splicing of an embryo-specific exon in AnkyrinG. Neurosci Res. 2018;135:13&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">29614249</ArticleId></ArticleIdList></Reference><Reference><Citation>Okano HJ, Darnell RB. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J Neurosci. 1997;17:3024&#x2013;3037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6573636</ArticleId><ArticleId IdType="pubmed">9096138</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin SJ, Kim JMH, Baughn M, Libby RT, Kim YJ, Fan Y, et al. Sporadic ALS has compartment-specific aberrant exon splicing and altered cell-matrix adhesion biology. Hum Mol Genet. 2010;19:313&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2796893</ArticleId><ArticleId IdType="pubmed">19864493</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J, Laurie P, Fan Y, Moore DH. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology. 2007;68:1576&#x2013;1582.</Citation><ArticleIdList><ArticleId IdType="pubmed">17485644</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa Ma X, Prudencio M, Koike Y, Vatsavayai SC, Kim G, Harbinski F et al (2021) TDP-43 represses cryptic exon inclusion in FTD/ALS gene UNC13A. 10.1101/2021.04.02.438213</Citation></Reference><Reference><Citation>Rotem N, Magen I, Ionescu A, Gershoni-Emek N, Altman T, Costa CJ, et al. ALS along the axons&#x2014;expression of coding and noncoding RNA differs in axons of ALS models. Sci Rep. 2017;7:44500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353576</ArticleId><ArticleId IdType="pubmed">28300211</ArticleId></ArticleIdList></Reference><Reference><Citation>De Santis R, Alfano V, de Turris V, Colantoni A, Santini L, Garone MG, et al. Mutant FUS and ELAVL4 (HuD) aberrant crosstalk in amyotrophic lateral sclerosis. Cell Rep. 2019;27:3818&#x2013;3831.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6613039</ArticleId><ArticleId IdType="pubmed">31242416</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheckel C, Drapeau E, Frias MA, Park CY, Fak J, Zucker-Scharff I, et al. Regulatory consequences of neuronal ELAV-like protein binding to coding and non-coding RNAs in human brain. Elife. 2016 doi: 10.7554/eLife.10421.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.10421</ArticleId><ArticleId IdType="pmc">PMC4798961</ArticleId><ArticleId IdType="pubmed">26894958</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr, Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ticozzi N, Vance C, Leclerc AL, Keagle P, Glass JD, McKenna-Yasek D, et al. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am J Med Genet B Neuropsychiatr Genet. 2011;156B:285&#x2013;290.</Citation><ArticleIdList><ArticleId IdType="pubmed">21438137</ArticleId></ArticleIdList></Reference><Reference><Citation>Urdaneta EC, Vieira-Vieira CH, Hick T, Wessels H-H, Figini D, Moschall R, et al. Purification of cross-linked RNA-protein complexes by phenol-toluol extraction. Nat Commun. 2019;10:990.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6397201</ArticleId><ArticleId IdType="pubmed">30824702</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck L, Callaerts P, Dermaut B. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis? Trends Mol Med. 2014;20:66&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">24355761</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S, Wang Y, Lin L, Si X, Wang T, Zhong X, et al. Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections. Virol J. 2014;11:192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4247557</ArticleId><ArticleId IdType="pubmed">25410318</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, So K, Peterson R, Bauer M, Ng H, Zhang Y, et al. Elav-mediated exon skipping and alternative polyadenylation of the Dscam1 gene are required for axon outgrowth. Cell Rep. 2019;27:3808&#x2013;3817.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092717</ArticleId><ArticleId IdType="pubmed">31242415</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Kim JR, van Bruggen R, Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol Cells. 2018;41:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Zhao J, Hou M, Wang Y, Zhang Y, Zhao X, et al. HuR and TIA1/TIAL1 are involved in regulation of alternative splicing of SIRT1 pre-mRNA. Int J Mol Sci. 2014;15:2946&#x2013;2958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3958892</ArticleId><ArticleId IdType="pubmed">24566137</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>